Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alternative Boost Approaches in Radiation Therapy IRreversible Electroporation Versus RADIAtioN BoosT for Intermediate Risk Prostate Cancer (IRRADIANT)

NCT07548164 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT07548164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alternative Boost Approaches in Radiation Therapy IRreversible Electroporation Versus RADIAtioN BoosT for Intermediate Risk Prostate Cancer (IRRADIANT)
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 3
Overall status
Recruiting
Start date
April 16, 2026
Completion date
April 16, 2029
Enrollment
224 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer